GlassScriptPhysician profile
John S Andrachuk
NPI 1124252374
$16,951.13
in general payments reported to CMS, 2019-2025
18 companies · $3,953 in 2025
The $3,953 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,397 · 2020: $220 · 2021: $400 · 2022: $2,495 · 2023: $1,697 · 2024: $5,790 · 2025: $3,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,079 · Travel and Lodging: $3,436 · Food and Beverage: $2,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,079.20 |
| Travel and Lodging | $3,435.53 |
| Food and Beverage | $2,925.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $5,382.19 | 2021-2024 | |
| Smith+Nephew, INC. | $4,487.05 | 2019-2025 | Acufex Meniscal Root Repair, Q-Fix, Healicoil |
| Zimmer Biomet Holdings, INC. | $2,059.05 | 2019-2025 | Oxford |
| Arthrex, INC. | $1,875.11 | 2022-2023 | |
| Stryker Corporation | $1,062.00 | 2019-2025 | Na, Iconix, Inspace |
| United Orthopedics LLC | $977.14 | 2022-2024 | |
| Ermi LLC | $241.15 | 2023-2024 | |
| Depuy Synthes Sales INC. | $145.01 | 2019 | |
| Vericel Corporation | $135.89 | 2019-2021 | |
| Intrinsic Therapeutics | $126.05 | 2025 | Barricaid Acd (Annular Closure Device) |
| Organogenesis INC. | $105.21 | 2022 | |
| Ferring Pharmaceuticals INC. | $97.52 | 2022-2025 | Euflexxa |
| Medical Device Business Services, INC. | $81.67 | 2019 | |
| Bioventus LLC | $46.12 | 2021 | |
| Davol INC. | $44.42 | 2025 | Arista |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $32.67 | 2021-2023 | Dermabond Prineo, Stratafix |
| Kuros Biosciences USA, INC | $30.28 | 2023 | |
| Protega Pharmaceutials INC | $22.60 | 2024 | Roxybond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andrachuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.